Indication
appendiceal cancer
6 clinical trials
7 products
Clinical trial
A Phase 1/2 Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Product
CBX-12Product
Systemic TreatmentClinical trial
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)Status: Recruiting, Estimated PCD: 2029-10-01
Clinical trial
Genetics of Appendix Cancer: The GAP StudyStatus: Recruiting, Estimated PCD: 2032-11-01
Product
Genetic profilingClinical trial
ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multi-center, Randomized Phase II Trial of Early Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal MetastasisStatus: Active (not recruiting), Estimated PCD: 2026-09-01
Product
HIPEC with Mitomycin-CProduct
EPIC + FUDR + LeucovorinClinical trial
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer: a Phase I StudyStatus: Recruiting, Estimated PCD: 2025-08-01
Product
PIPAC with Nal-IRIClinical trial
A Phase I Trial of Intraperitoneal LSTA1 in Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface MalignancyStatus: Recruiting, Estimated PCD: 2028-12-01
Product
CRS-HIPEC + LSTA1